Exploring Analyst Estimates for TransMedics (TMDX) Q1 Earnings, Beyond Revenue and EPS

Wall Street analysts expect TransMedics (TMDX) to post quarterly loss of $0.05 per share in its upcoming report, which indicates a year-over-year increase of 37.5%. Revenues are expected to be $83.32 million, up 100.5% from the year-ago quarter.The current level reflects an upward revision of 32.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a compa ...